Healthcare Sector Stocks
The Healthcare sector has a total of 1051 stocks, with a combined market cap of $9.53 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 50.57.
Market Cap
9.53T
Revenue
4.67T
Profits
188.51B
PE Ratio
50.57
Profit Margin
4.04%
Dividend Yield
0.39%
1050 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.13T | 4.76% | 1,966,918 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 616.74B | 0.79% | 4,002,254 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 508.50B | 2.13% | 2,752,557 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 370.08B | 4.22% | 5,487,670 | 450.06B |
| 5 | MRK | Merck & Co., Inc. | 368.40B | 1.32% | 4,719,102 | 66.57B |
| 6 | NVS | Novartis AG | 286.07B | 2.95% | 1,004,212 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 259.60B | 3.48% | 2,749,427 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 256.13B | 2.90% | 1,300,800 | 46.34B |
| 9 | AMGN | Amgen Inc. | 237.96B | 3.29% | 1,170,240 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 197.44B | 3.71% | 3,151,086 | 30.46B |
| 11 | ABT | Abbott Laboratories | 181.11B | 2.27% | 5,083,999 | 46.59B |
| 12 | NVO | Novo Nordisk A/S | 174.87B | 3.83% | 8,475,027 | 50.34B |
| 13 | PFE | Pfizer Inc. | 169.37B | 1.73% | 16,572,029 | 63.70B |
| 14 | DHR | Danaher Corporation | 162.59B | 2.94% | 2,638,042 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 150.39B | 1.30% | 854,184 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 129.28B | 2.32% | 741,592 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 124.97B | 3.21% | 5,724,320 | 49.19B |
| 18 | CVS | CVS Health Corporation | 118.11B | 2.17% | 3,996,023 | 412.65B |
| 19 | MDT | Medtronic plc | 116.65B | 1.12% | 7,221,121 | 37.54B |
| 20 | MCK | McKesson Corporation | 115.86B | 1.76% | 303,924 | 410.98B |
| 21 | SYK | Stryker Corporation | 111.92B | 3.61% | 1,154,452 | 25.84B |
| 22 | HCA | HCA Healthcare, Inc. | 101.40B | -0.45% | 497,989 | 78.01B |
| 23 | GSK | GSK plc | 98.44B | 2.87% | 3,398,043 | 44.05B |
| 24 | SNY | Sanofi | 97.15B | 1.51% | 2,916,474 | 55.89B |
| 25 | MRNA | Moderna, Inc. | 95.22B | 5.39% | 11,583,207 | 2.23B |
| 26 | ELV | Elevance Health, Inc. | 93.42B | 0.63% | 551,115 | 201.11B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 80.44B | 3.49% | 445,624 | 15.53B |
| 28 | CI | The Cigna Group | 79.24B | 3.56% | 637,594 | 282.38B |
| 29 | COR | Cencora, Inc. | 65.24B | 1.69% | 604,824 | 332.77B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 64.67B | 3.58% | 2,466,669 | 28.42B |
| 31 | BSX | Boston Scientific Corporation | 63.42B | 1.77% | 7,536,982 | 21.00B |
| 32 | CAH | Cardinal Health, Inc. | 58.43B | 1.85% | 614,377 | 254.25B |
| 33 | NTRA | Natera, Inc. | 57.88B | 1.72% | 612,205 | 2.71B |
| 34 | ARGX | argenx SE | 53.83B | 3.72% | 211,216 | 5.32B |
| 35 | BDX | Becton, Dickinson and Company | 52.33B | 1.70% | 754,540 | 22.48B |
| 36 | HUM | Humana Inc. | 52.27B | 1.85% | 365,946 | 145.68B |
| 37 | VEEV | Veeva Systems Inc. | 50.52B | 4.93% | 1,370,823 | 3.46B |
| 38 | EW | Edwards Lifesciences Corporation | 49.84B | 0.02% | 1,255,501 | 6.51B |
| 39 | A | Agilent Technologies, Inc. | 49.55B | 1.02% | 473,374 | 7.37B |
| 40 | MDLN | Medline Inc. | 48.17B | 1.98% | 3,428,778 | 29.94B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 48.10B | 1.38% | 4,408,686 | 17.32B |
| 42 | IQV | IQVIA Holdings Inc. | 44.36B | 2.87% | 353,597 | 16.98B |
| 43 | WAT | Waters Corporation | 43.64B | 1.72% | 303,363 | 4.64B |
| 44 | HLN | Haleon plc | 43.27B | 3.15% | 13,052,389 | 14.80B |
| 45 | IDXX | IDEXX Laboratories, Inc. | 42.67B | 2.39% | 227,432 | 4.55B |
| 46 | ONC | BeOne Medicines AG | 42.35B | 5.97% | 324,126 | 6.13B |
| 47 | RVMD | Revolution Medicines, Inc. | 41.01B | -1.13% | 679,335 | - |
| 48 | ILMN | Illumina, Inc. | 40.48B | -1.35% | 1,348,893 | 4.49B |
| 49 | BIIB | Biogen Inc. | 35.28B | 2.55% | 818,846 | 10.03B |
| 50 | CNC | Centene Corporation | 35.07B | 1.18% | 2,180,205 | 180.30B |
| 51 | RPRX | Royalty Pharma plc | 34.40B | 1.41% | 1,271,832 | 2.54B |
| 52 | RMD | ResMed Inc. | 33.83B | 2.22% | 267,743 | 5.65B |
| 53 | MTD | Mettler-Toledo International Inc. | 32.89B | 2.01% | 89,833 | 4.13B |
| 54 | ZTS | Zoetis Inc. | 32.57B | 4.69% | 1,887,082 | 9.53B |
| 55 | DXCM | DexCom, Inc. | 32.46B | 3.04% | 1,811,658 | 4.97B |
| 56 | ALC | Alcon Inc. | 31.99B | 4.03% | 1,123,437 | 10.86B |
| 57 | GEHC | GE HealthCare Technologies Inc. | 31.83B | 2.94% | 1,374,449 | 21.27B |
| 58 | ALNY | Alnylam Pharmaceuticals, Inc. | 31.21B | 3.90% | 681,025 | 4.80B |
| 59 | WST | West Pharmaceutical Services, Inc. | 26.90B | 2.04% | 135,031 | 3.33B |
| 60 | DGX | Quest Diagnostics Incorporated | 26.16B | 1.52% | 278,485 | 11.56B |
| 61 | LH | Labcorp Holdings Inc. | 26.13B | 1.54% | 144,298 | 14.35B |
| 62 | PHG | Koninklijke Philips N.V. | 24.86B | 1.76% | 707,725 | 20.18B |
| 63 | ROIV | Roivant Sciences Ltd. | 24.60B | 1.28% | 1,416,627 | 7.53M |
| 64 | UTHR | United Therapeutics Corporation | 23.57B | 1.76% | 194,170 | 3.15B |
| 65 | INCY | Incyte Corporation | 23.06B | 1.96% | 640,662 | 5.82B |
| 66 | GMAB | Genmab A/S | 22.76B | 3.19% | 2,392,682 | 4.13B |
| 67 | BNTX | BioNTech SE | 22.69B | 1.88% | 457,621 | 3.03B |
| 68 | GH | Guardant Health, Inc. | 22.19B | 1.44% | 519,435 | 1.18B |
| 69 | THC | Tenet Healthcare Corporation | 22.16B | 1.34% | 213,115 | 21.81B |
| 70 | STE | STERIS plc | 21.84B | 3.11% | 250,726 | 6.04B |
| 71 | INSM | Insmed Incorporated | 21.42B | 0.31% | 1,177,138 | 1.14B |
| 72 | VTRS | Viatris Inc. | 20.82B | 3.96% | 3,229,932 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 17.92B | 2.35% | 628,940 | 8.51B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.55B | 1.97% | 115,908 | 2.78B |
| 75 | RVTY | Revvity, Inc. | 17.39B | 2.44% | 1,159,528 | 2.91B |
| 76 | EXEL | Exelixis, Inc. | 15.66B | 3.62% | 1,374,884 | 2.44B |
| 77 | SOLV | Solventum Corporation | 14.97B | 0.81% | 257,466 | 8.31B |
| 78 | ASND | Ascendis Pharma A/S | 14.93B | 0.16% | 132,676 | 1.20B |
| 79 | CRL | Charles River Laboratories International, Inc. | 14.66B | 1.72% | 382,115 | 4.00B |
| 80 | NBIX | Neurocrine Biosciences, Inc. | 13.97B | 1.10% | 491,023 | 3.37B |
| 81 | JAZZ | Jazz Pharmaceuticals plc | 13.92B | 2.28% | 444,620 | 4.60B |
| 82 | HALO | Halozyme Therapeutics, Inc. | 13.74B | 3.60% | 1,099,079 | 1.66B |
| 83 | ICLR | ICON Public Limited Company | 13.38B | 2.64% | 344,847 | 8.29B |
| 84 | BAX | Baxter International Inc. | 13.30B | 3.71% | 1,647,564 | 11.47B |
| 85 | BBIO | BridgeBio Pharma, Inc. | 13.14B | 3.50% | 917,932 | 713.07M |
| 86 | BTSG | BrightSpring Health Services, Inc. | 12.92B | -2.07% | 556,880 | 14.37B |
| 87 | EHC | Encompass Health Corporation | 12.69B | 1.60% | 460,353 | 6.21B |
| 88 | PEN | Penumbra, Inc. | 12.64B | 0.25% | 139,343 | 1.50B |
| 89 | TEM | Tempus AI, Inc. | 12.49B | 1.29% | 3,650,379 | 1.43B |
| 90 | CORT | Corcept Therapeutics Incorporated | 12.30B | -2.07% | 289,743 | 830.81M |
| 91 | SMMT | Summit Therapeutics Inc. | 12.30B | 1.62% | 2,629,526 | - |
| 92 | SNN | Smith & Nephew plc | 12.10B | 4.20% | 1,133,833 | 6.30B |
| 93 | DVA | DaVita Inc. | 11.91B | 3.39% | 170,804 | 14.01B |
| 94 | ELAN | Elanco Animal Health Incorporated | 11.79B | 4.68% | 1,710,334 | 5.02B |
| 95 | FMS | Fresenius Medical Care AG | 11.61B | 2.79% | 1,122,578 | 22.19B |
| 96 | TECH | Bio-Techne Corporation | 11.37B | 0.05% | 1,566,846 | 1.22B |
| 97 | MOH | Molina Healthcare, Inc. | 11.11B | 1.96% | 290,251 | 42.47B |
| 98 | UHS | Universal Health Services, Inc. | 11.09B | 1.20% | 166,443 | 18.11B |
| 99 | BMRN | BioMarin Pharmaceutical Inc. | 10.97B | 2.79% | 959,952 | 3.41B |
| 100 | AVTR | Avantor, Inc. | 10.86B | 2.29% | 2,397,435 | 6.56B |
| 101 | RDY | Dr. Reddy's Laboratories Limited | 10.86B | 1.65% | 1,481,514 | 3.50B |
| 102 | COO | The Cooper Companies, Inc. | 10.81B | 3.61% | 1,055,078 | 4.24B |
| 103 | IBRX | ImmunityBio, Inc. | 10.70B | 1.92% | 12,664,715 | 165.79M |
| 104 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.58B | -0.42% | 96,951 | 1.28B |
| 105 | ALGN | Align Technology, Inc. | 10.52B | 2.49% | 352,643 | 4.14B |
| 106 | GMED | Globus Medical, Inc. | 10.51B | 2.62% | 563,876 | 3.14B |
| 107 | RGEN | Repligen Corporation | 10.41B | 3.53% | 416,047 | 785.10M |
| 108 | PCVX | Vaxcyte, Inc. | 10.38B | -2.35% | 846,404 | - |
| 109 | OSCR | Oscar Health, Inc. | 10.37B | -2.01% | 2,591,459 | 15.32B |
| 110 | ENSG | The Ensign Group, Inc. | 10.33B | 1.68% | 111,449 | 5.49B |
| 111 | GKOS | Glaukos Corporation | 9.83B | -0.71% | 246,491 | 612.84M |
| 112 | KRYS | Krystal Biotech, Inc. | 9.82B | 0.37% | 113,886 | 440.48M |
| 113 | BIO | Bio-Rad Laboratories, Inc. | 9.76B | 0.73% | 100,018 | 2.59B |
| 114 | HSIC | Henry Schein, Inc. | 9.69B | 1.65% | 300,797 | 13.60B |
| 115 | PODD | Insulet Corporation | 9.61B | 3.46% | 382,115 | 3.05B |
| 116 | QGEN | Qiagen N.V. | 9.59B | 1.76% | 351,054 | 2.10B |
| 117 | TXG | 10x Genomics, Inc. | 9.22B | -3.16% | 2,465,707 | 616.91M |
| 118 | KYMR | Kymera Therapeutics, Inc. | 8.97B | 0.95% | 202,719 | 105.00M |
| 119 | CYTK | Cytokinetics, Incorporated | 8.92B | 1.12% | 617,488 | 67.67M |
| 120 | PTGX | Protagonist Therapeutics, Inc. | 8.91B | 1.05% | 249,531 | 281.99M |
| 121 | TWST | Twist Bioscience Corporation | 8.90B | -4.22% | 2,406,214 | 431.80M |
| 122 | CAI | Caris Life Sciences, Inc. | 8.81B | 3.06% | 1,528,826 | 989.61M |
| 123 | AXSM | Axsome Therapeutics, Inc. | 8.63B | 1.62% | 373,581 | 776.57M |
| 124 | BRKR | Bruker Corporation | 8.57B | 1.19% | 673,561 | 3.50B |
| 125 | HNGE | Hinge Health, Inc. | 8.51B | 0.50% | 701,569 | 720.06M |
| 126 | ABVX | ABIVAX Société Anonyme | 8.34B | 4.19% | 688,289 | 5.33M |
| 127 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.24B | -0.07% | 995,203 | 669.50M |
| 128 | TGTX | TG Therapeutics, Inc. | 7.94B | 2.92% | 898,473 | 799.54M |
| 129 | ATR | AptarGroup, Inc. | 7.91B | 3.46% | 84,737 | 3.93B |
| 130 | HQY | HealthEquity, Inc. | 7.64B | 2.82% | 258,387 | 1.36B |
| 131 | PACS | PACS Group, Inc. | 7.48B | 4.96% | 422,681 | 5.55B |
| 132 | SYRE | Spyre Therapeutics, Inc. | 7.43B | 1.12% | 517,487 | - |
| 133 | IONS | Ionis Pharmaceuticals, Inc. | 7.32B | 3.19% | 883,929 | 874.09M |
| 134 | PRAX | Praxis Precision Medicines, Inc. | 6.93B | 3.87% | 288,965 | 7.46M |
| 135 | AMRX | Amneal Pharmaceuticals, Inc. | 6.86B | 4.21% | 1,072,813 | 3.12B |
| 136 | ALKS | Alkermes plc | 6.75B | 2.92% | 1,062,247 | 1.67B |
| 137 | GRFS | Grifols, S.A. | 6.74B | 3.80% | 669,944 | 8.48B |
| 138 | CHE | Chemed Corporation | 6.73B | 0.72% | 77,302 | 2.60B |
| 139 | LNTH | Lantheus Holdings, Inc. | 6.53B | 0.04% | 419,476 | 1.56B |
| 140 | IOVA | Iovance Biotherapeutics, Inc. | 6.51B | 1.13% | 5,120,748 | 324.97M |
| 141 | HIMS | Hims & Hers Health, Inc. | 6.46B | -0.07% | 6,271,396 | 2.58B |
| 142 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.24B | 1.47% | 561,026 | 840.85M |
| 143 | BLTE | Belite Bio, Inc | 6.22B | 1.08% | 84,756 | - |
| 144 | GRAL | GRAIL, Inc. | 6.13B | -1.78% | 344,143 | 165.26M |
| 145 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.11B | 2.30% | 158,137 | 239.92M |
| 146 | LGND | Ligand Pharmaceuticals Incorporated | 5.96B | 1.28% | 98,707 | 290.54M |
| 147 | BLCO | Bausch + Lomb Corporation | 5.85B | 2.18% | 273,315 | 5.32B |
| 148 | IMVT | Immunovant, Inc. | 5.75B | -0.29% | 683,150 | - |
| 149 | CGON | CG Oncology, Inc. | 5.53B | 0.86% | 195,403 | 6.23M |
| 150 | DOCS | Doximity, Inc. | 5.53B | 3.61% | 964,312 | 655.57M |
| 151 | RDNT | RadNet, Inc. | 5.52B | 1.49% | 132,353 | 2.27B |
| 152 | HAE | Haemonetics Corporation | 5.43B | -1.40% | 278,453 | 1.35B |
| 153 | WAY | Waystar Holding Corp. | 5.39B | 4.54% | 1,665,920 | 1.21B |
| 154 | TFX | Teleflex Incorporated | 5.38B | 3.01% | 334,489 | 2.25B |
| 155 | RGC | Regencell Bioscience Holdings Limited | 5.37B | 33.54% | 769,627 | - |
| 156 | MIRM | Mirum Pharmaceuticals, Inc. | 5.35B | 3.11% | 239,986 | 618.07M |
| 157 | MMSI | Merit Medical Systems, Inc. | 5.33B | 2.50% | 351,760 | 1.58B |
| 158 | KOD | Kodiak Sciences Inc. | 5.31B | 4.45% | 656,229 | - |
| 159 | STVN | Stevanato Group S.p.A. | 5.26B | -0.26% | 128,698 | 1.40B |
| 160 | ERAS | Erasca, Inc. | 5.18B | 0.75% | 1,937,309 | - |
| 161 | SHC | Sotera Health Company | 5.13B | 1.41% | 829,173 | 1.22B |
| 162 | PTCT | PTC Therapeutics, Inc. | 5.12B | 2.76% | 353,498 | 1.01B |
| 163 | COGT | Cogent Biosciences, Inc. | 5.09B | 4.12% | 892,136 | - |
| 164 | TVTX | Travere Therapeutics, Inc. | 5.04B | 0.39% | 927,755 | 591.33M |
| 165 | SRRK | Scholar Rock Holding Corporation | 5.00B | 3.59% | 813,955 | - |
| 166 | CRSP | CRISPR Therapeutics AG | 4.96B | 2.19% | 608,793 | 13.39M |
| 167 | ORKA | Oruka Therapeutics, Inc. | 4.94B | -2.67% | 403,677 | - |
| 168 | MMED | MiniMed Group, Inc. | 4.93B | 4.22% | 9,652,389 | 3.22B |
| 169 | CON | Concentra Group Holdings Parent, Inc. | 4.91B | 2.75% | 554,935 | 2.29B |
| 170 | LFST | LifeStance Health Group, Inc. | 4.76B | -0.48% | 1,233,909 | 1.58B |
| 171 | MANE | Veradermics, Incorporated | 4.76B | 0.39% | 354,193 | - |
| 172 | BLLN | BillionToOne, Inc. | 4.69B | 1.48% | 172,024 | 397.41M |
| 173 | OPCH | Option Care Health, Inc. | 4.67B | 0.10% | 2,041,168 | 5.69B |
| 174 | DFTX | Definium Therapeutics, Inc. | 4.65B | 1.05% | 699,379 | - |
| 175 | HTFL | HeartFlow, Inc. | 4.35B | 1.05% | 795,195 | 212.07M |
| 176 | ITGR | Integer Holdings Corporation | 4.31B | 0.09% | 289,519 | 1.84B |
| 177 | LIVN | LivaNova PLC | 4.21B | 0.38% | 114,546 | 1.47B |
| 178 | DNTH | Dianthus Therapeutics, Inc. | 4.19B | 0.13% | 353,933 | 1.90M |
| 179 | ICUI | ICU Medical, Inc. | 4.17B | 2.60% | 91,061 | 2.16B |
| 180 | EWTX | Edgewise Therapeutics, Inc. | 4.16B | 3.42% | 676,908 | - |
| 181 | ABCL | AbCellera Biologics Inc. | 4.09B | 2.14% | 3,789,368 | 66.17M |
| 182 | ADPT | Adaptive Biotechnologies Corporation | 4.07B | -0.51% | 716,075 | 308.08M |
| 183 | INDV | Indivior Pharmaceuticals, Inc. | 4.05B | 0.41% | 443,573 | 1.33B |
| 184 | RLAY | Relay Therapeutics, Inc. | 3.84B | 2.70% | 823,143 | 10.35M |
| 185 | LEGN | Legend Biotech Corporation | 3.83B | 3.73% | 838,484 | 1.27B |
| 186 | NHC | National HealthCare Corporation | 3.79B | 3.11% | 43,142 | 1.56B |
| 187 | TNGX | Tango Therapeutics, Inc. | 3.78B | 0.95% | 1,265,760 | 53.81M |
| 188 | NVST | Envista Holdings Corporation | 3.74B | 2.15% | 1,485,757 | 2.86B |
| 189 | VCYT | Veracyte, Inc. | 3.65B | 4.37% | 484,384 | 561.90M |
| 190 | OGN | Organon & Co. | 3.61B | 0.11% | 295,426 | 6.13B |
| 191 | ARQT | Arcutis Biotherapeutics, Inc. | 3.61B | 8.75% | 1,702,414 | 463.98M |
| 192 | IRTC | iRhythm Holdings, Inc. | 3.53B | 0.91% | 122,509 | 825.34M |
| 193 | TLX | Telix Pharmaceuticals Limited | 3.51B | -1.13% | 103,575 | 890.79M |
| 194 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.50B | 3.14% | 363,116 | -665.00K |
| 195 | CDNA | CareDx, Inc. | 3.46B | 3.34% | 514,313 | 458.09M |
| 196 | ACAD | Acadia Pharmaceuticals Inc. | 3.39B | 2.21% | 538,198 | 1.14B |
| 197 | XENE | Xenon Pharmaceuticals Inc. | 3.36B | 2.45% | 578,610 | 7.50M |
| 198 | IDYA | IDEAYA Biosciences, Inc. | 3.27B | 0.15% | 298,816 | 234.13M |
| 199 | PBLS | Parabilis Medicines, Inc. | 3.24B | 1.31% | 282,396 | 148.00K |
| 200 | TARS | Tarsus Pharmaceuticals, Inc. | 3.22B | 1.40% | 363,660 | 606.33M |
| 201 | PLSE | Pulse Biosciences, Inc. | 3.21B | -2.85% | 133,544 | 1.19M |
| 202 | LQDA | Liquidia Corporation | 3.13B | 3.09% | 4,123,098 | 450.91M |
| 203 | VKTX | Viking Therapeutics, Inc. | 3.13B | 5.22% | 2,906,458 | - |
| 204 | WRBY | Warby Parker Inc. | 3.05B | -1.04% | 1,892,290 | 911.61M |
| 205 | CELC | Celcuity Inc. | 2.96B | 1.02% | 814,303 | - |
| 206 | DNLI | Denali Therapeutics Inc. | 2.93B | 2.63% | 633,631 | 3.60M |
| 207 | ELVN | Enliven Therapeutics, Inc. | 2.92B | 1.53% | 484,417 | - |
| 208 | RCUS | Arcus Biosciences, Inc. | 2.91B | 1.51% | 548,954 | 117.00M |
| 209 | ACHC | Acadia Healthcare Company, Inc. | 2.91B | -1.47% | 582,291 | 3.37B |
| 210 | ATRC | AtriCure, Inc. | 2.90B | -0.44% | 334,491 | 569.62M |
| 211 | DYN | Dyne Therapeutics, Inc. | 2.84B | 1.20% | 876,626 | - |
| 212 | PRVA | Privia Health Group, Inc. | 2.83B | 2.33% | 628,683 | 2.36B |
| 213 | AVAH | Aveanna Healthcare Holdings Inc. | 2.74B | 1.62% | 441,084 | 2.60B |
| 214 | NRIX | Nurix Therapeutics, Inc. | 2.69B | 4.10% | 1,174,632 | 701.94M |
| 215 | ZLAB | Zai Lab Limited | 2.66B | 5.13% | 317,833 | 449.61M |
| 216 | NEOG | Neogen Corporation | 2.64B | -0.33% | 908,176 | 884.00M |
| 217 | PGEN | Precigen, Inc. | 2.64B | 0.14% | 1,911,188 | 85.72M |
| 218 | TMDX | TransMedics Group, Inc. | 2.61B | -0.45% | 359,469 | 668.47M |
| 219 | HCM | HUTCHMED (China) Limited | 2.54B | 3.04% | 34,119 | 549.12M |
| 220 | GRDN | Guardian Pharmacy Services, Inc. | 2.53B | -1.72% | 85,372 | 1.46B |
| 221 | NAMS | NewAmsterdam Pharma Company N.V. | 2.51B | 4.75% | 308,668 | 7.12M |
| 222 | CLOV | Clover Health Investments, Corp. | 2.49B | -2.30% | 1,633,837 | 2.48B |
| 223 | ADMA | ADMA Biologics, Inc. | 2.42B | 4.45% | 1,065,139 | 512.28M |
| 224 | BKD | Brookdale Senior Living Inc. | 2.42B | 0.05% | 4,557,202 | 2.93B |
| 225 | BEAM | Beam Therapeutics Inc. | 2.42B | 2.20% | 851,090 | 156.04M |
| 226 | MBX | MBX Biosciences, Inc. | 2.40B | 2.11% | 107,514 | - |
| 227 | BHC | Bausch Health Companies Inc. | 2.35B | 6.62% | 1,248,510 | 10.85B |
| 228 | SUPN | Supernus Pharmaceuticals, Inc. | 2.35B | 0.52% | 214,987 | 830.44M |
| 229 | PBH | Prestige Consumer Healthcare Inc. | 2.34B | 2.26% | 164,754 | 1.10B |
| 230 | RXRX | Recursion Pharmaceuticals, Inc. | 2.32B | 15.78% | 42,720,011 | 54.86M |
| 231 | UFPT | UFP Technologies, Inc. | 2.32B | 2.69% | 56,392 | 631.64M |
| 232 | PRGO | Perrigo Company plc | 2.30B | 3.70% | 1,103,846 | 4.14B |
| 233 | SLS | SELLAS Life Sciences Group, Inc. | 2.27B | -5.56% | 2,813,046 | - |
| 234 | HRMY | Harmony Biosciences Holdings, Inc. | 2.26B | 3.41% | 241,517 | 959.90M |
| 235 | CLDX | Celldex Therapeutics, Inc. | 2.24B | 2.39% | 308,970 | 158.00K |
| 236 | AUPH | Aurinia Pharmaceuticals Inc. | 2.23B | 1.08% | 464,161 | 311.51M |
| 237 | IRON | Disc Medicine, Inc. | 2.21B | 3.29% | 121,625 | - |
| 238 | VRDN | Viridian Therapeutics, Inc. | 2.20B | 5.55% | 984,408 | 71.13M |
| 239 | NEO | NeoGenomics, Inc. | 2.19B | 1.18% | 419,524 | 766.30M |
| 240 | MD | Pediatrix Medical Group, Inc. | 2.19B | 2.14% | 187,937 | 1.95B |
| 241 | ADUS | Addus HomeCare Corporation | 2.15B | 0.57% | 68,569 | 1.48B |
| 242 | WGS | GeneDx Holdings Corp. | 2.15B | 4.84% | 242,555 | 454.43M |
| 243 | PGNY | Progyny, Inc. | 2.13B | -0.36% | 395,921 | 1.31B |
| 244 | NVAX | Novavax, Inc. | 2.12B | 1.66% | 4,038,933 | 413.80M |
| 245 | VCEL | Vericel Corporation | 2.11B | 2.48% | 186,398 | 306.30M |
| 246 | FTRE | Fortrea Holdings Inc. | 2.11B | 3.80% | 920,989 | 2.68B |
| 247 | AXGN | Axogen, Inc. | 2.09B | 1.54% | 371,487 | 251.17M |
| 248 | PHVS | Pharvaris N.V. | 2.09B | -0.93% | 274,478 | - |
| 249 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.05B | -0.12% | 1,574,776 | 940.61M |
| 250 | VERA | Vera Therapeutics, Inc. | 2.05B | 6.39% | 521,560 | - |
| 251 | BFLY | Butterfly Network, Inc. | 2.05B | 1.05% | 2,061,120 | 112.14M |
| 252 | ADRX | ADARx Pharmaceuticals, Inc. | 2.02B | 1.18% | 114,941 | 6.13M |
| 253 | LKFT | Lakefront Biotherapeutics NV | 2.00B | 2.24% | 149,418 | 1.13B |
| 254 | TRLV | Trulieve Cannabis Corp. | 1.99B | 3.71% | 782,127 | 1.14B |
| 255 | INSP | Inspire Medical Systems, Inc. | 1.99B | 1.12% | 166,363 | 898.74M |
| 256 | ASTH | Astrana Health, Inc. | 1.98B | 2.52% | 81,694 | 3.84B |
| 257 | IMNM | Immunome, Inc. | 1.97B | 1.05% | 385,623 | 4.02M |
| 258 | ALMR | Alamar Biosciences, Inc. | 1.93B | 9.54% | 431,458 | 100.42M |
| 259 | LMAT | LeMaitre Vascular, Inc. | 1.92B | 1.61% | 115,548 | 262.43M |
| 260 | MLYS | Mineralys Therapeutics, Inc. | 1.92B | 4.58% | 407,617 | - |
| 261 | SGRY | Surgery Partners, Inc. | 1.91B | -0.54% | 1,125,138 | 3.37B |
| 262 | ALVO | Alvotech | 1.91B | 3.68% | 503,776 | 494.61M |
| 263 | AGIO | Agios Pharmaceuticals, Inc. | 1.91B | 3.29% | 609,138 | 98.34M |
| 264 | SRPT | Sarepta Therapeutics, Inc. | 1.87B | 5.41% | 1,699,237 | 1.97B |
| 265 | SDGR | Schrödinger, Inc. | 1.87B | -0.12% | 954,586 | 259.04M |
| 266 | ZYME | Zymeworks Inc. | 1.84B | 4.60% | 258,469 | 37.13M |
| 267 | XERS | Xeris Biopharma Holdings, Inc. | 1.84B | 3.07% | 691,635 | 335.41M |
| 268 | ESTA | Establishment Labs Holdings Inc. | 1.83B | 5.87% | 218,576 | 245.82M |
| 269 | PVLA | Palvella Therapeutics, Inc. | 1.82B | 2.90% | 83,892 | - |
| 270 | URGN | UroGen Pharma Ltd. | 1.81B | 1.45% | 159,799 | 188.73M |
| 271 | XNCR | Xencor, Inc. | 1.80B | 3.33% | 185,193 | 104.97M |
| 272 | VIR | Vir Biotechnology, Inc. | 1.78B | 0.86% | 718,821 | 303.23M |
| 273 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.77B | 3.89% | 693,712 | 208.78M |
| 274 | MESO | Mesoblast Limited | 1.76B | 0.58% | 91,552 | 120.25M |
| 275 | SEPN | Septerna, Inc. | 1.76B | 3.94% | 102,897 | 98.88M |
| 276 | XRAY | DENTSPLY SIRONA Inc. | 1.75B | 3.79% | 1,631,915 | 3.64B |
| 277 | BHVN | Biohaven Ltd. | 1.72B | 4.07% | 595,859 | - |
| 278 | SNDA | Sonida Senior Living, Inc. | 1.72B | 1.20% | 94,811 | 481.07M |
| 279 | TRVI | Trevi Therapeutics, Inc. | 1.71B | -0.25% | 636,132 | - |
| 280 | ARDT | Ardent Health, Inc. | 1.70B | 1.00% | 234,595 | 6.41B |
| 281 | PSNL | Personalis, Inc. | 1.70B | - | 1,199,633 | 69.67M |
| 282 | ALHC | Alignment Healthcare, Inc. | 1.69B | -0.73% | 2,518,760 | 4.58B |
| 283 | ATEC | Alphatec Holdings, Inc. | 1.68B | 4.07% | 1,465,610 | 815.05M |
| 284 | ZBIO | Zenas BioPharma, Inc. | 1.67B | 2.86% | 210,397 | 1.00M |
| 285 | NUVB | Nuvation Bio Inc. | 1.65B | 0.53% | 1,616,197 | 169.90M |
| 286 | GENB | Generate Biomedicines, Inc. | 1.65B | 2.40% | 576,624 | 26.48M |
| 287 | NVCR | NovoCure Limited | 1.64B | 1.88% | 251,863 | 699.19M |
| 288 | NTLA | Intellia Therapeutics, Inc. | 1.64B | 2.27% | 1,797,420 | 59.51M |
| 289 | OMCL | Omnicell, Inc. | 1.63B | 1.13% | 116,226 | 1.25B |
| 290 | OCUL | Ocular Therapeutix, Inc. | 1.61B | 1.94% | 963,586 | 52.06M |
| 291 | KMTS | Kestra Medical Technologies, Ltd. | 1.61B | 5.97% | 54,044 | 106.73M |
| 292 | AZTA | Azenta, Inc. | 1.60B | -1.64% | 625,617 | 613.81M |
| 293 | GPCR | Structure Therapeutics Inc. | 1.59B | 2.03% | 598,087 | - |
| 294 | PAHC | Phibro Animal Health Corporation | 1.59B | 3.08% | 54,992 | 1.52B |
| 295 | BRVE | Braveheart Bio, Inc. | 1.58B | 0.26% | 73,540 | - |
| 296 | STOK | Stoke Therapeutics, Inc. | 1.57B | 4.79% | 230,892 | 27.59M |
| 297 | CMPS | COMPASS Pathways plc | 1.56B | 0.09% | 881,871 | - |
| 298 | ANIP | ANI Pharmaceuticals, Inc. | 1.56B | 3.45% | 85,193 | 978.38M |
| 299 | KRSA | Korsana Biosciences, Inc. | 1.55B | -0.87% | 112,567 | - |
| 300 | COAG | Hemab Therapeutics Holdings, Inc. | 1.54B | 10.35% | 166,527 | - |
| 301 | ETON | Eton Pharmaceuticals, Inc. | 1.53B | 1.42% | 163,356 | 105.60M |
| 302 | INVA | Innoviva, Inc. | 1.53B | 1.03% | 222,243 | 440.00M |
| 303 | MAZE | Maze Therapeutics, Inc. | 1.53B | 4.77% | 258,132 | 20.00M |
| 304 | AMN | AMN Healthcare Services, Inc. | 1.51B | 3.82% | 439,506 | 3.43B |
| 305 | IMCR | Immunocore Holdings plc | 1.51B | 3.53% | 89,774 | 430.78M |
| 306 | ABSI | Absci Corporation | 1.51B | 0.57% | 2,177,432 | 1.56M |
| 307 | QURE | uniQure N.V. | 1.50B | 2.79% | 671,558 | 18.67M |
| 308 | RARE | Ultragenyx Pharmaceutical Inc. | 1.49B | 1.81% | 1,293,156 | 717.00M |
| 309 | PNTG | The Pennant Group, Inc. | 1.47B | 3.33% | 101,252 | 1.10B |
| 310 | HCSG | Healthcare Services Group, Inc. | 1.47B | 2.09% | 141,423 | 1.86B |
| 311 | KLRA | Kailera Therapeutics, Inc. | 1.47B | 5.77% | 480,408 | - |
| 312 | CERT | Certara, Inc. | 1.47B | 2.72% | 625,645 | 421.75M |
| 313 | AGL | agilon health, inc. | 1.46B | -0.30% | 44,397 | 5.92B |
| 314 | PCRX | Pacira BioSciences, Inc. | 1.45B | -0.14% | 763,289 | 746.16M |
| 315 | CNMD | CONMED Corporation | 1.43B | 5.93% | 102,665 | 1.37B |
| 316 | RAPP | Rapport Therapeutics, Inc. | 1.42B | 4.84% | 134,584 | 20.00M |
| 317 | ANAB | AnaptysBio, Inc. | 1.41B | 1.41% | 92,712 | 106.09M |
| 318 | NUTX | Nutex Health Inc. | 1.38B | 2.09% | 87,647 | 846.72M |
| 319 | OMER | Omeros Corporation | 1.36B | 1.57% | 299,540 | 38.42M |
| 320 | FRNM | Freenome, Inc. | 1.35B | 2.95% | 437,494 | 35.41M |
| 321 | INBX | Inhibrx Biosciences, Inc. | 1.32B | 5.23% | 87,798 | 1.30M |
| 322 | TYRA | Tyra Biosciences, Inc. | 1.32B | 2.35% | 170,732 | - |
| 323 | AAPG | Ascentage Pharma Group International | 1.30B | -0.71% | 4,662 | 94.61M |
| 324 | ORIC | ORIC Pharmaceuticals, Inc. | 1.29B | 7.51% | 446,035 | - |
| 325 | NKTR | Nektar Therapeutics | 1.29B | 2.22% | 359,931 | 54.59M |
| 326 | GHRS | GH Research PLC | 1.29B | 0.92% | 152,390 | - |
| 327 | USPH | U.S. Physical Therapy, Inc. | 1.27B | 0.24% | 107,497 | 804.27M |
| 328 | KARD | Kardigan, Inc. | 1.26B | - | 193,758 | - |
| 329 | TRAX | First Tracks Biotherapeutics, Inc. | 1.24B | 1.73% | 720,743 | - |
| 330 | INNV | InnovAge Holding Corp. | 1.24B | - | 96,221 | 989.71M |
| 331 | TSHA | Taysha Gene Therapies, Inc. | 1.23B | 7.98% | 1,955,234 | 5.49M |
| 332 | DRTS | Alpha Tau Medical Ltd. | 1.22B | -1.96% | 291,841 | - |
| 333 | SVRA | Savara Inc. | 1.21B | 0.42% | 759,082 | - |
| 334 | SNDX | Syndax Pharmaceuticals, Inc. | 1.21B | 0.15% | 865,244 | 252.25M |
| 335 | LBRX | LB Pharmaceuticals Inc | 1.20B | 9.46% | 430,674 | - |
| 336 | CRON | Cronos Group Inc. | 1.19B | 2.22% | 305,530 | 179.09M |
| 337 | OPK | OPKO Health, Inc. | 1.17B | 14.60% | 44,663,720 | 587.90M |
| 338 | GDRX | GoodRx Holdings, Inc. | 1.17B | 1.48% | 281,500 | 785.23M |
| 339 | BCAX | Bicara Therapeutics Inc. | 1.16B | 1.38% | 219,416 | - |
| 340 | BVS | Bioventus Inc. | 1.16B | 2.07% | 92,206 | 581.85M |
| 341 | AHG | Akso Health Group | 1.16B | -1.94% | 1,065 | 13.83M |
| 342 | VOR | Vor Biopharma Inc. | 1.15B | 4.11% | 341,538 | - |
| 343 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.15B | 3.22% | 110,266 | 730.02M |
| 344 | OMDA | Omada Health, Inc. | 1.14B | 2.63% | 543,822 | 309.76M |
| 345 | IRMD | IRADIMED CORPORATION | 1.14B | -0.42% | 28,437 | 86.34M |
| 346 | DMRA | Damora Therapeutics, Inc. | 1.14B | - | 99,486 | - |
| 347 | NBTX | Nanobiotix S.A. | 1.14B | 2.73% | 55,766 | 13.15M |
| 348 | STAA | STAAR Surgical Company | 1.12B | 2.66% | 267,017 | 339.59M |
| 349 | TNDM | Tandem Diabetes Care, Inc. | 1.11B | -0.44% | 3,377,285 | 1.04B |
| 350 | ENOV | Enovis Corporation | 1.11B | 3.39% | 402,783 | 2.30B |
| 351 | REPL | Replimune Group, Inc. | 1.10B | 2.55% | 700,990 | - |
| 352 | AVLN | Avalyn Pharma Inc. | 1.10B | 4.35% | 55,750 | - |
| 353 | VSTM | Verastem, Inc. | 1.09B | 16.34% | 6,624,226 | 87.53M |
| 354 | HROW | Harrow, Inc. | 1.07B | 5.18% | 232,527 | 275.59M |
| 355 | AORT | Artivion, Inc. | 1.07B | 2.09% | 139,742 | 471.47M |
| 356 | JANX | Janux Therapeutics, Inc. | 1.06B | 1.52% | 210,301 | 24.00M |
| 357 | TDOC | Teladoc Health, Inc. | 1.06B | 0.69% | 1,401,291 | 2.49B |
| 358 | CBLL | CeriBell, Inc. | 1.06B | 4.29% | 359,075 | 101.96M |
| 359 | IART | Integra LifeSciences Holdings Corporation | 1.05B | 2.24% | 345,091 | 1.65B |
| 360 | HSTM | HealthStream, Inc. | 1.03B | 0.36% | 39,129 | 321.12M |
| 361 | LMRI | Lumexa Imaging Holdings, Inc. | 1.03B | 1.52% | 187,336 | 1.04B |
| 362 | CSTL | Castle Biosciences, Inc. | 1.03B | 1.69% | 105,295 | 357.28M |
| 363 | PRCT | PROCEPT BioRobotics Corporation | 1.02B | 1.83% | 295,349 | 337.34M |
| 364 | MNKD | MannKind Corporation | 1.01B | 3.64% | 1,829,932 | 393.63M |
| 365 | SLBT | SL Science Holding Limited | 997.97M | 12.90% | 84,357 | 3.27M |
| 366 | IMTX | Immatics N.V. | 970.50M | 1.43% | 517,039 | 47.65M |
| 367 | LTGO | Latigo Biotherapeutics, Inc. | 969.30M | 4.43% | 100,611 | - |
| 368 | QDEL | QuidelOrtho Corporation | 960.06M | 0.94% | 588,628 | 2.67B |
| 369 | SPTX | Seaport Therapeutics, Inc. | 954.72M | 6.92% | 82,768 | - |
| 370 | MGTX | MeiraGTx Holdings plc | 941.22M | 4.14% | 307,329 | 397.50M |
| 371 | AKTS | Aktis Oncology, Inc. | 920.50M | 0.36% | 275,382 | 10.06M |
| 372 | BBNX | Beta Bionics, Inc. | 898.60M | 1.19% | 283,385 | 119.01M |
| 373 | ANRO | Alto Neuroscience, Inc. | 895.50M | 5.11% | 190,449 | - |
| 374 | RIGL | Rigel Pharmaceuticals, Inc. | 891.68M | 1.95% | 80,007 | 276.79M |
| 375 | SIBN | SI-BONE, Inc. | 889.20M | 1.90% | 189,672 | 213.60M |
| 376 | MLTX | MoonLake Immunotherapeutics | 885.96M | 2.66% | 387,554 | - |
| 377 | JBIO | Jade Biosciences, Inc. | 877.64M | 2.68% | 365,741 | - |
| 378 | CGEM | Cullinan Therapeutics, Inc. | 874.58M | -0.37% | 411,352 | - |
| 379 | KURA | Kura Oncology, Inc. | 873.59M | 2.19% | 801,766 | 77.23M |
| 380 | AHCO | AdaptHealth Corp. | 852.48M | 2.24% | 382,885 | 3.36B |
| 381 | IAM | Iambic Therapeutics, Inc. | 851.79M | 102.82% | 874,815 | 18.25M |
| 382 | ODTX | Odyssey Therapeutics, Inc. | 850.31M | 6.90% | 52,622 | 99.00K |
| 383 | GLUE | Monte Rosa Therapeutics, Inc. | 848.87M | 1.12% | 365,068 | 28.73M |
| 384 | ABUS | Arbutus Biopharma Corporation | 840.85M | 1.43% | 790,360 | 181.72M |
| 385 | CRVS | Corvus Pharmaceuticals, Inc. | 828.59M | 5.01% | 410,558 | - |
| 386 | INMD | InMode Ltd. | 827.44M | 0.81% | 281,440 | 374.63M |
| 387 | SGP | SpyGlass Pharma, Inc. | 826.17M | 4.26% | 13,082 | - |
| 388 | ARDX | Ardelyx, Inc. | 824.81M | 3.76% | 2,265,393 | 450.89M |
| 389 | GMRS | GMR Solutions Inc. | 823.85M | -1.12% | 109,892 | 5.88B |
| 390 | ALMS | Alumis Inc. | 821.91M | 4.79% | 999,598 | 7.40M |
| 391 | AVBP | ArriVent BioPharma, Inc. | 818.02M | 2.41% | 207,422 | - |
| 392 | GERN | Geron Corporation | 787.03M | 2.94% | 2,183,572 | 204.56M |
| 393 | HELP | Helus Pharma Inc. | 781.74M | 3.08% | 648,651 | - |
| 394 | ANL | Adlai Nortye Group Ltd. | 779.86M | 11.31% | 303,441 | 18.06M |
| 395 | VREX | Varex Imaging Corporation | 775.31M | 0.03% | 239,857 | 865.00M |
| 396 | DNA | Ginkgo Bioworks Holdings, Inc. | 773.07M | -0.43% | 1,207,882 | 132.42M |
| 397 | APMD | Apnimed, Inc. | 768.50M | 7.14% | 131,842 | 115.12M |
| 398 | OBX | Obsidian Therapeutics, Inc. | 765.37M | 1.39% | 52,862 | - |
| 399 | COLL | Collegium Pharmaceutical, Inc. | 758.55M | 3.51% | 281,567 | 808.21M |
| 400 | IVA | Inventiva S.A. | 749.16M | 6.97% | 1,745,465 | 2.81M |
| 401 | SANA | Sana Biotechnology, Inc. | 731.94M | 4.94% | 1,393,749 | - |
| 402 | LXRX | Lexicon Pharmaceuticals, Inc. | 723.05M | 1.56% | 599,849 | 41.47M |
| 403 | IMMX | Immix Biopharma, Inc. | 722.08M | 2.35% | 714,907 | - |
| 404 | ACHV | Achieve Life Sciences, Inc. | 712.09M | -1.14% | 496,193 | - |
| 405 | CTKB | Cytek Biosciences, Inc. | 702.56M | 0.19% | 329,825 | 206.71M |
| 406 | FDMT | 4D Molecular Therapeutics, Inc. | 697.73M | 3.52% | 298,627 | 92.01M |
| 407 | GYRE | Gyre Therapeutics, Inc. | 696.64M | 1.55% | 54,806 | 109.82M |
| 408 | STLN | Starling Oncology, Inc. | 689.46M | 3.92% | 408,104 | 587.24M |
| 409 | PHAR | Pharming Group N.V. | 689.45M | 1.82% | 2,907 | 366.48M |
| 410 | ATTO | Attovia Therapeutics, Inc. | 689.33M | 0.94% | 208,258 | 1.80M |
| 411 | MDXG | MiMedx Group, Inc. | 688.72M | 0.53% | 701,206 | 355.17M |
| 412 | CADL | Candel Therapeutics, Inc. | 683.31M | -1.54% | 493,365 | - |
| 413 | PHR | Phreesia, Inc. | 677.19M | 2.63% | 578,190 | 507.79M |
| 414 | OABI | OmniAb, Inc. | 674.61M | 1.98% | 271,661 | 38.46M |
| 415 | ANNX | Annexon, Inc. | 667.32M | -4.09% | 1,175,189 | - |
| 416 | AURA | Aura Biosciences, Inc. | 659.56M | 3.08% | 289,883 | - |
| 417 | AVTX | Avalo Therapeutics, Inc. | 656.43M | 3.38% | 381,512 | 59.00K |
| 418 | DSGN | Design Therapeutics, Inc. | 628.32M | 3.19% | 161,972 | - |
| 419 | PRME | Prime Medicine, Inc. | 627.11M | 12.62% | 3,656,379 | 4.07M |
| 420 | IRWD | Ironwood Pharmaceuticals, Inc. | 625.43M | 5.14% | 1,113,136 | 389.32M |
| 421 | CLYM | Climb Bio, Inc. | 617.15M | 4.42% | 243,543 | - |
| 422 | NVCT | Nuvectis Pharma, Inc. | 613.84M | 4.67% | 65,087 | - |
| 423 | WVE | Wave Life Sciences, Inc. | 612.82M | 0.65% | 1,285,655 | 65.37M |
| 424 | ZVRA | Zevra Therapeutics, Inc. | 610.47M | 0.49% | 187,658 | 136.07M |
| 425 | AVR | Anteris Technologies Global Corp. | 608.36M | -0.32% | 323,103 | 2.24M |
| 426 | PHAT | Phathom Pharmaceuticals, Inc. | 607.64M | 3.38% | 480,521 | 239.66M |
| 427 | SLDB | Solid Biosciences Inc. | 604.21M | 3.11% | 808,821 | - |
| 428 | SOPH | SOPHiA GENETICS SA | 601.85M | 0.14% | 598,437 | 86.17M |
| 429 | KIDS | OrthoPediatrics Corp. | 600.26M | 3.33% | 67,790 | 252.72M |
| 430 | PACB | Pacific Biosciences of California, Inc. | 593.69M | -4.02% | 7,739,474 | 159.27M |
| 431 | OLMA | Olema Pharmaceuticals, Inc. | 591.48M | -0.59% | 399,632 | - |
| 432 | WEAV | Weave Communications, Inc. | 591.19M | - | 450,419 | 257.79M |
| 433 | FLGT | Fulgent Genetics, Inc. | 586.63M | 1.48% | 44,364 | 323.93M |
| 434 | CRMD | CorMedix Inc. | 585.75M | 1.69% | 787,228 | 462.25M |
| 435 | SGMT | Sagimet Biosciences Inc. | 570.11M | 6.56% | 685,784 | - |
| 436 | ETRA | Electra Therapeutics, Inc. | 555.49M | -1.01% | 78,855 | - |
| 437 | EVH | Evolent Health, Inc. | 555.12M | 3.81% | 1,683,773 | 2.10B |
| 438 | SLN | Silence Therapeutics plc | 551.22M | 1.95% | 1,081,592 | 615.00K |
| 439 | PBYI | Puma Biotechnology, Inc. | 550.79M | 4.61% | 126,136 | 231.24M |
| 440 | FTH | Faeth Therapeutics, Inc. | 549.11M | 6.25% | 96,441 | - |
| 441 | STTK | Shattuck Labs, Inc. | 548.99M | 2.63% | 252,582 | 1.00M |
| 442 | VALN | Valneva SE | 548.13M | 2.47% | 3,961 | 163.30M |
| 443 | CBIO | Crescent Biopharma, Inc. | 545.29M | 1.27% | 95,795 | 11.88M |
| 444 | DBVT | DBV Technologies S.A. | 536.57M | 2.09% | 236,551 | 5.04M |
| 445 | DRUG | Bright Minds Biosciences Inc. | 529.03M | 7.85% | 63,706 | - |
| 446 | AQST | Aquestive Therapeutics, Inc. | 527.15M | -8.89% | 2,535,495 | 54.09M |
| 447 | SSII | SS Innovations International, Inc. | 527.01M | -2.59% | 14,379 | 52.40M |
| 448 | TCMD | Tactile Systems Technology, Inc. | 522.81M | 2.99% | 76,302 | 350.31M |
| 449 | CTMX | CytomX Therapeutics, Inc. | 519.69M | 6.95% | 1,063,738 | 18.30M |
| 450 | EVO | Evotec SE | 510.17M | -1.05% | 109,976 | 819.47M |
| 451 | ACRS | Aclaris Therapeutics, Inc. | 510.04M | 2.51% | 994,328 | 8.22M |
| 452 | DCTH | Delcath Systems, Inc. | 509.73M | -0.20% | 89,125 | 95.42M |
| 453 | EOLS | Evolus, Inc. | 506.61M | 6.23% | 393,366 | 316.49M |
| 454 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 455 | MASS | 908 Devices Inc. | 491.87M | 0.59% | 120,540 | 60.84M |
| 456 | SGHT | Sight Sciences, Inc. | 488.63M | 7.52% | 121,941 | 83.38M |
| 457 | MNPR | Monopar Therapeutics Inc. | 486.23M | -0.90% | 58,971 | - |
| 458 | NGNE | Neurogene Inc. | 481.57M | 8.50% | 180,724 | 925.00K |
| 459 | BLSM | BlossomHill Therapeutics, Inc. | 478.52M | -1.34% | 85,925 | - |
| 460 | YDES | YD Bio Limited | 477.40M | 5.97% | 29,134 | 1.24M |
| 461 | ANGO | AngioDynamics, Inc. | 476.48M | 2.53% | 480,630 | 325.38M |
| 462 | BWAY | BrainsWay Ltd. | 475.65M | 2.09% | 49,884 | 60.70M |
| 463 | TLRY | Tilray Brands, Inc. | 472.99M | 2.71% | 1,615,565 | 963.10M |
| 464 | NRC | NRC Health | 468.82M | 3.74% | 35,712 | 140.00M |
| 465 | ARVN | Arvinas, Inc. | 467.51M | 4.84% | 210,983 | 316.70M |
| 466 | ALLO | Allogene Therapeutics, Inc. | 466.41M | 3.85% | 2,820,609 | 4.64M |
| 467 | OCS | Oculis Holding AG | 465.46M | 5.16% | 175,204 | 1.45M |
| 468 | RGNX | REGENXBIO Inc. | 461.43M | 1.60% | 398,254 | 174.48M |
| 469 | ENTX | Entera Bio Ltd. | 459.16M | 5.60% | 844,390 | 42.00K |
| 470 | AUTL | Autolus Therapeutics plc | 456.47M | 1.48% | 1,007,835 | 117.39M |
| 471 | CERS | Cerus Corporation | 453.43M | 0.45% | 562,310 | 221.55M |
| 472 | ALT | Altimmune, Inc. | 452.25M | 0.65% | 2,168,872 | 31.00K |
| 473 | MPLT | MapLight Therapeutics, Inc. | 449.90M | 3.65% | 357,889 | - |
| 474 | KMDA | Kamada Ltd. | 449.74M | 2.76% | 38,768 | 191.85M |
| 475 | NPCE | NeuroPace, Inc. | 441.07M | 2.31% | 36,944 | 106.99M |
| 476 | EPRX | Eupraxia Pharmaceuticals Inc. | 439.94M | 1.82% | 186,548 | - |
| 477 | PROK | ProKidney Corp. | 439.88M | -1.02% | 475,820 | 818.00K |
| 478 | PRTA | Prothena Corporation plc | 437.39M | 1.79% | 138,066 | 54.53M |
| 479 | OVID | Ovid Therapeutics Inc. | 436.49M | 2.05% | 560,160 | 1.58M |
| 480 | RZLT | Rezolute, Inc. | 429.03M | -3.31% | 1,103,628 | - |
| 481 | DMAC | DiaMedica Therapeutics Inc. | 428.17M | 3.66% | 70,633 | - |
| 482 | SENS | Senseonics Holdings, Inc. | 428.02M | -0.06% | 317,704 | 48.55M |
| 483 | ASMB | Assembly Biosciences, Inc. | 420.96M | 0.71% | 62,841 | 74.85M |
| 484 | MYGN | Myriad Genetics, Inc. | 418.95M | 5.54% | 382,441 | 806.60M |
| 485 | TECX | Tectonic Therapeutic, Inc. | 416.79M | 1.72% | 62,629 | - |
| 486 | CAPR | Capricor Therapeutics, Inc. | 411.62M | 7.44% | 1,597,510 | 11.13M |
| 487 | RCEL | AVITA Medical, Inc. | 411.02M | 1.45% | 191,062 | 75.63M |
| 488 | TKNO | Alpha Teknova, Inc. | 410.45M | -1.86% | 206,659 | 43.70M |
| 489 | AGMB | AgomAb Therapeutics NV | 408.76M | -4.49% | 47,532 | - |
| 490 | ZURA | Zura Bio Limited | 408.23M | -3.40% | 2,827,655 | - |
| 491 | EIKN | Eikon Therapeutics, Inc. | 407.32M | 7.28% | 350,263 | - |
| 492 | CTEV | Claritev Corporation | 405.30M | -0.10% | 53,286 | 994.67M |
| 493 | CYH | Community Health Systems, Inc. | 403.87M | - | 296,996 | 11.98B |
| 494 | SPRY | ARS Pharmaceuticals, Inc. | 401.77M | 2.80% | 1,094,592 | 116.93M |
| 495 | OFIX | Orthofix Medical Inc. | 393.07M | 4.32% | 109,311 | 833.19M |
| 496 | AUNA | Auna S.A. | 392.27M | 0.95% | 52,815 | 1.37B |
| 497 | SCTX | Scribe Therapeutics Inc. | 389.42M | -0.96% | 106,807 | 33.30M |
| 498 | SI | Shoulder Innovations, Inc. | 389.42M | 4.67% | 16,446 | 60.06M |
| 499 | TRXB | TRex Bio, Inc. | 384.72M | 5.85% | 23,809 | - |
| 500 | CARL | Carlsmed, Inc. | 382.51M | 1.16% | 11,610 | 63.30M |